LGALS9 and neoplasm: Fooladinezhad et al. and Mohammad-Ganji et al. have both shown that the TIM-3-Gal-9 interaction is a key player in the domains of infection, inflammation, tumor immunity, and autoimmunity control, as the downstream effects work to suppress the immune cell responses [143,145].